FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2915735309> ?p ?o ?g. }

• W2915735309 endingPage "1981" @default.
• W2915735309 startingPage "1970" @default.
• W2915735309 abstract "TMPRSS2‐ERG expression in blood has been correlated with low docetaxel benefit in metastatic castration‐resistant prostate cancer (mCRPC). This multicenter study aimed to prospectively asses its role as a taxane‐resistance biomarker in blood and retrospectively in tumors, exploring also the impact of prior abiraterone/enzalutamide (A/E) in patients and in vitro. TMPRSS2‐ERG was tested by quantitative reverse‐transcription PCR. We included 204 patients (137 blood and 124 tumor samples) treated with taxanes. TMPRSS2‐ERG expression was correlated with prostate‐specific antigen (PSA)‐progression‐free survival (PFS), radiological‐PFS (RX‐PFS), and overall survival (OS). Independent association with survival was evaluated by multivariate Cox modeling. In vitro ERG knockdown and combinatorial and sequential experiments with enzalutamide and docetaxel were performed in VCaP cells. Prior A/E (HR 1.8, 95% CI 1.2–2.8) and blood TMPRSS2‐ERG detection (HR 2, 95% CI 1.1–3.7) were independently associated to lower PSA‐PFS. In patients without prior A/E, blood and tumor TMPRSS2‐ERG independently predicted lower PSA‐PFS (HR 3.3, 95% CI 1.4–7.9 and HR 1.8, 95% CI 1.02–3.3, respectively) to taxanes. When prior A/E was administered, TMPRSS2‐ERG was not associated with outcome. There was a significant interaction between blood TMPRSS2‐ERG and prior A/E related to PSA‐PFS ( p = 0.032) and RX‐PFS ( p = 0.009). In vitro stable ERG inhibition did not sensitize VCaP cells to docetaxel. Concomitant enzalutamide and taxanes were synergistic, but prior enzalutamide reduced docetaxel cytotoxicity in VCaP cells. Enzalutamide induced the expression of neuroendocrine markers and reduced that of E‐cadherin. We conclude that prior hormone‐therapy may influence taxanes response and TMPRSS2‐ERG prognostic value. Thus, multiple and sequential biomarkers are needed in CRPC follow‐up evaluation." @default.
• W2915735309 created "2019-03-02" @default.
• W2915735309 creator A5001340494 @default.
• W2915735309 creator A5001994148 @default.
• W2915735309 creator A5008678006 @default.
• W2915735309 creator A5010040304 @default.
• W2915735309 creator A5019200201 @default.
• W2915735309 creator A5023395087 @default.
• W2915735309 creator A5024309839 @default.
• W2915735309 creator A5025430979 @default.
• W2915735309 creator A5026620381 @default.
• W2915735309 creator A5026726668 @default.
• W2915735309 creator A5038937574 @default.
• W2915735309 creator A5043620430 @default.
• W2915735309 creator A5059115998 @default.
• W2915735309 creator A5060467306 @default.
• W2915735309 creator A5061938039 @default.
• W2915735309 creator A5079620361 @default.
• W2915735309 creator A5080734034 @default.
• W2915735309 creator A5085349056 @default.
• W2915735309 creator A5089513581 @default.
• W2915735309 creator A5091309316 @default.
• W2915735309 date "2019-03-23" @default.
• W2915735309 modified "2023-10-18" @default.
• W2915735309 title "The influence of treatment sequence in the prognostic value of <i>TMPRSS2‐ERG</i> as biomarker of taxane resistance in castration‐resistant prostate cancer" @default.
• W2915735309 cites W1844925317 @default.
• W2915735309 cites W1992624438 @default.
• W2915735309 cites W2007521294 @default.
• W2915735309 cites W2015437876 @default.
• W2915735309 cites W2019607817 @default.
• W2915735309 cites W2031507616 @default.
• W2915735309 cites W2041193073 @default.
• W2915735309 cites W2058484579 @default.
• W2915735309 cites W2073630816 @default.
• W2915735309 cites W2079298594 @default.
• W2915735309 cites W2080439368 @default.
• W2915735309 cites W2096439168 @default.
• W2915735309 cites W2120292596 @default.
• W2915735309 cites W2121158863 @default.
• W2915735309 cites W2123526148 @default.
• W2915735309 cites W2131456094 @default.
• W2915735309 cites W2166374791 @default.
• W2915735309 cites W2167331614 @default.
• W2915735309 cites W2244169135 @default.
• W2915735309 cites W2289244923 @default.
• W2915735309 cites W2419426348 @default.
• W2915735309 cites W2467297086 @default.
• W2915735309 cites W2571250257 @default.
• W2915735309 cites W2747733421 @default.
• W2915735309 cites W2788051020 @default.
• W2915735309 cites W2800410357 @default.
• W2915735309 cites W2805640141 @default.
• W2915735309 cites W2806462579 @default.
• W2915735309 cites W2841858285 @default.
• W2915735309 cites W2884825769 @default.
• W2915735309 cites W2898090458 @default.
• W2915735309 doi "https://doi.org/10.1002/ijc.32238" @default.
• W2915735309 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30807643" @default.
• W2915735309 hasPublicationYear "2019" @default.
• W2915735309 type Work @default.
• W2915735309 sameAs 2915735309 @default.
• W2915735309 citedByCount "11" @default.
• W2915735309 countsByYear W29157353092019 @default.
• W2915735309 countsByYear W29157353092020 @default.
• W2915735309 countsByYear W29157353092022 @default.
• W2915735309 crossrefType "journal-article" @default.
• W2915735309 hasAuthorship W2915735309A5001340494 @default.
• W2915735309 hasAuthorship W2915735309A5001994148 @default.
• W2915735309 hasAuthorship W2915735309A5008678006 @default.
• W2915735309 hasAuthorship W2915735309A5010040304 @default.
• W2915735309 hasAuthorship W2915735309A5019200201 @default.
• W2915735309 hasAuthorship W2915735309A5023395087 @default.
• W2915735309 hasAuthorship W2915735309A5024309839 @default.
• W2915735309 hasAuthorship W2915735309A5025430979 @default.
• W2915735309 hasAuthorship W2915735309A5026620381 @default.
• W2915735309 hasAuthorship W2915735309A5026726668 @default.
• W2915735309 hasAuthorship W2915735309A5038937574 @default.
• W2915735309 hasAuthorship W2915735309A5043620430 @default.
• W2915735309 hasAuthorship W2915735309A5059115998 @default.
• W2915735309 hasAuthorship W2915735309A5060467306 @default.
• W2915735309 hasAuthorship W2915735309A5061938039 @default.
• W2915735309 hasAuthorship W2915735309A5079620361 @default.
• W2915735309 hasAuthorship W2915735309A5080734034 @default.
• W2915735309 hasAuthorship W2915735309A5085349056 @default.
• W2915735309 hasAuthorship W2915735309A5089513581 @default.
• W2915735309 hasAuthorship W2915735309A5091309316 @default.
• W2915735309 hasBestOaLocation W29157353091 @default.
• W2915735309 hasConcept C103796816 @default.
• W2915735309 hasConcept C118487528 @default.
• W2915735309 hasConcept C121608353 @default.
• W2915735309 hasConcept C126322002 @default.
• W2915735309 hasConcept C126894567 @default.
• W2915735309 hasConcept C143998085 @default.
• W2915735309 hasConcept C2776551883 @default.
• W2915735309 hasConcept C2777511904 @default.
• W2915735309 hasConcept C2777899217 @default.
• W2915735309 hasConcept C2778042024 @default.
• W2915735309 hasConcept C2778971682 @default.

• next